Paul Carpenter, MB.BS.

Paul Carpenter MB.BS.
FACULTY MEMBER

Paul Carpenter, MB.BS.

Professor
Clinical Research Division, Fred Hutch

Fax: 206.667.1034
Mail Stop: D5-290

Dr. Paul Carpenter leads a team at Fred Hutch and its clinical care partner, Seattle Cancer Care Alliance, that supports bone marrow and stem cell transplant survivors long after they finish initial treatment. As director of the world-class post-transplant Adult Clinical Care Long-Term Follow-Up Program, known as the LTFU, Dr. Carpenter and his colleagues are helping transplant survivors and their primary care physicians manage post-treatment complications as patients recover and resume their lives. The LTFU also serves as a model for the training of transplant physicians. In his own research, Dr. Carpenter is developing better treatments for graft-vs.-host disease. GVHD is a common complication of bone marrow transplantation that can cause serious illness and even death. In GVHD, donor immune cells attack the patient’s healthy cells. Dr. Carpenter leads clinical trials of new therapies for acute and chronic GVHD. He is studying new ways to overcome long-term complications of GVHD treatments and prevent relapse after transplant.

Other Appointments & Affiliations

Medical Director, Long-Term Follow-Up Clinical Service
Seattle Cancer Care Alliance

Professor, Division of Pediatrics
University of Washington School of Medicine

Education

B.Sc., Medicine, University of Sydney, Australia

MB.BS., Medicine and Surgery, University of Sydney, Australia

Current Projects

Dr. Carpenter is participating in a multi-site trial that will collect and analyze samples from pediatric HCT patients in order to validate biomarkers of acute and chronic GVHD. Enrollment recently completed on a phase I/II clinical trial to determine if giving patients nilotinib 100 days after HCT is effective in reducing relapse in patients with Philadelphia chromosome-positive leukemias. Data analysis is beginning on a national multicenter trial he is leading that compared two chronic graft-versus-host disease drug regimens.

Dr. Carpenter in the News

'None of us practices in a vacuum'

Hutch News - September 21, 2006

Caring for results

Hutch News - April 06, 2006

Care in the hands of a healer

Hutch News - April 07, 2005

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.